Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Specialty Distributors Continue To Provide Effective Delivery and Value to the U.S. Healthcare Ecosystem
New benchmarking data released by the HDA Research Foundation showcase the continued value of HDA specialty distributors to the U.S. healthcare ecosystem. As illustrated in the 15th edition of Specialty Pharmaceutical Distribution Facts Figures and Trends, the average specialty distributor delivered medicines to treat chronic, complex or rare diseases to 51,469 unique ship-to points in 2022.
Specialty Distributors Serve a Range of Healthcare Providers
New benchmarking data released today by the HDA Research Foundation reveal the continued efficiency and reliability that HDA specialty distributors deliver to providers treating patients with chronic, complex or rare diseases. As illustrated in the 14th edition of Specialty Pharmaceutical Distribution Facts Figures and Trends, a typical HDA-member specialty distributor delivered products to approximately 56,000 provider ship-to points daily in 2021.
Specialty Distributors Navigated Pandemic’s First Year To Reliably Deliver Lifesaving Medications
Data published today by the Healthcare Distribution Alliance (HDA) Research Foundation indicate HDA-member specialty distributors adapted to ensure reliable delivery of complex medications during the first year of the COVID-19 response. As reported in the 2021 edition of Specialty Pharmaceutical Distribution Facts, Figures and Trends, individual specialty distributors serve as a critical nexus between 191 manufacturers and a record-high 50,000 healthcare provider ship-to points.